diabetes

Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting

Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting

Forbes

Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments

Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments

Forbes

Strong Drug Performance Boosts Santarus Higher

Strong Drug Performance Boosts Santarus Higher

Forbes

Steve Nissen: The FDA Meeting On Avandia Will Be A 'Whitewash'

Steve Nissen: The FDA Meeting On Avandia Will Be A 'Whitewash'

Pharmalot

MannKind's Afrezza And The Oramed Threat

MannKind's Afrezza And The Oramed Threat

Seeking Alpha

Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin

Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin

Seeking Alpha

Roche exploring sale of diabetes device unit

Roche exploring sale of diabetes device unit

Yahoo/Reuters

Baby Boomers Are Money-Making Machines For Big Pharma

Baby Boomers Are Money-Making Machines For Big Pharma

Seeking Alpha

3 Drug Catalysts to Watch in 2013

3 Drug Catalysts to Watch in 2013

Motley Fool

Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says

Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says

Fierce Pharma